Status: Recruiting
A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses
The goal of this clinical trial is to learn about deucravacitinib treatment in adults with inflammatory epidermal genodermatoses . The main question it aims to answer are: describe efficacity and safety of this treatment. Participants will take treatments and have to use bullets during the study period.
Participants needed: 10
Trial details
Phase: Phase 2Age: 18-99Biological sex: AllType: InterventionalSponsor: Centre Hospitalier Universitaire de NiceUpdated: Aug 5, 2025Locations: 2
Eligibility criteria
Subject has congenital skin fragility with skin and/or mucosal blisters, a clini... [+2]
Subjects with another form of ICI ie Netherton syndrome, Kid syndrome etc. [+2]